Biliary Atresia

Intro & Patho - Blocked Bile Blues

• Progressive, idiopathic fibro-obliterative disease of neonatal extrahepatic (± intrahepatic) bile ducts.
• Results in: cholestasis → biliary cirrhosis → end-stage liver disease.
• Classic triad: persistent jaundice (conjugated), acholic stools, dark urine.
• Types:
  • Embryonic/Fetal (10-20%): Jaundice from birth. Often with anomalies (e.g., BASM - Biliary Atresia Splenic Malformation).
  • Perinatal/Acquired (80-90%): Jaundice develops after a few weeks. Possible viral/immune trigger.

⭐ Perinatal/acquired form (80-90%) is more common than embryonic/fetal form, typically presenting after a jaundice-free interval.

• Pathogenesis: Unknown insult (viral/immune?) → cholangiocyte damage → inflammation → progressive fibrosis & obliteration of biliary tree.

Signs & Dx - Yellow Alert Clues

Yellow Alert Clues (Clinical):

• Persistent Jaundice: >2 wks (term), >3 wks (preterm)
• Acholic Stools (pale/clay-colored)
• Dark Urine (conjugated bilirubin)
• Hepatomegaly (firm, progressive)

Diagnostic Pathway:

• Labs: ↑ Direct Bilirubin, ↑ GGT, ↑ ALP.
• Ultrasound (USG):
  • Key: Triangular Cord (TC) sign (>4mm), absent/small gallbladder.
  • 

  • ⭐ The 'triangular cord sign' on ultrasound (echogenic fibrous tissue anterior to portal vein) is highly suggestive of Biliary Atresia.

• HIDA Scan: (Phenobarbital x 5 days) → No gut excretion by 24 hrs.
• Liver Biopsy: Bile duct proliferation, plugs, portal fibrosis. Confirms.
• Intraoperative Cholangiogram (IOC): Definitive.

Treatment Time - Kasai's Conduit Cure

• Kasai Portoenterostomy (Hepatoportoenterostomy):
  • Primary surgery; Roux-en-Y jejunal loop to porta hepatis.
  • Crucial timing: Ideally before 60 days of life.

    ⭐ Kasai portoenterostomy performed before 60 days of life offers the best chance of bile drainage and native liver survival.

  • Goal: Establish bile flow, delay cirrhosis.
• Post-Kasai Management:
  • Prophylactic antibiotics (vs. cholangitis).
  • Ursodeoxycholic acid (UDCA) for bile flow.
  • Fat-soluble vitamins (A, D, E, K) support.
• Liver Transplantation:
  • Indicated for Kasai failure or end-stage liver disease.
  • Ultimate treatment for most.

oka

Outcomes & Issues - Future Flow Forecast

• Kasai Portoenterostomy:
  • Success ↑ if age < 60-90 days at surgery.
  • Aim: Achieve bile drainage, clear jaundice.
• Common Complications:
  • ⭐ > Ascending cholangitis is the most common complication after Kasai portoenterostomy, often recurrent.
  • Portal hypertension: Varices, splenomegaly.
  • Fat malabsorption: Deficiencies of vitamins A, D, E, K.
  • Progressive biliary cirrhosis.
• Long-Term Outlook:
  • Majority require liver transplantation (LT).
  • Native liver survival: ~30-50% at 5 years post-Kasai.
  • Post-LT survival rates are high.
• Follow-up:
  • Regular LFTs, ultrasound.
  • Nutritional support (MCT oil, fat-soluble vitamins).
  • UDCA, prophylactic antibiotics (variable use).

High‑Yield Points - ⚡ Biggest Takeaways

• Persistent neonatal jaundice (>2 weeks), acholic stools, dark urine, and hepatomegaly are cardinal signs.
• Key lab findings: ↑ conjugated bilirubin and significantly ↑ serum GGT.
• Intraoperative cholangiogram is the gold standard for diagnosis.
• Kasai portoenterostomy (hepatoportoenterostomy) is the initial surgical intervention, ideally performed before 60-90 days of age.
• Liver transplantation is often required for failed Kasai or late diagnosis.
• Frequently associated with polysplenia syndrome (Biliary Atresia Splenic Malformation - BASM).
• Type III (atresia at the porta hepatis) is the most common anatomical variant (>90%).